Fee-for-Service (FFS) Preferred Drug List (PDL) update

Having trouble viewing this email? View it as a Web page.

Health Care Authority (HCA) logo

Apple Health (Medicaid) Provider Alert

Effective for claims with dates of service on and after July 1, 2018, Washington Apple Health (Medicaid), administered by the Health Care Authority, has updated the Fee-for-Service (FFS) Preferred Drug List (PDL). This is an update to the July 1, 2018, list published earlier in June 2018.

The agency made the following additional changes to the FFS PDL:

Analygesics – Opioid: Long Acting- Agonist       
The agency struck hydromorphone ER* from the Preferred Drugs List and
moved oxycodone ER* to the Nonpreferred Drugs List.

Analygesics: Migraine Agents – 5-HT1 Agonists
The agency struck naratriptan HCl from the Nonpreferred Drugs List.

Psychotherapeutic and Neurological Agents – MISC:
ADHD/Anti-Narcolepsy – Stimulants – Amphetamines
The agency moved methamphetamine to the Nonpreferred Drugs List and added PA required.

Please see the agency’s
Prescription Drug Program Billing Guide page to access the FFS PDL.